Background Phthalates, the esters of phthalic acid, are widely used as plasticizers in many consumer products. Phthalate plasticizers are mainly used in the polyvinyl Chloride (PVC) products including plastic containers, toys, or flooring materials, and comprise 10 to 60 % of plastic products by weight [1]. Phthalates are also utilized as solvents of cosmetics, liquid soaps, or pesticides. About 6 million tons of phthalates were produced worldwide in 2004, of which Di (2-ethylhexyl) phthalate (DEHP) accounted for half of the entire production [2]. Phthalates are easily released from products into the environment or food by leaching, migration, evaporation or natural degradation [3]. Most phthalates are absorbed through ingestion, while low molecular weight phthalates such as Dibutyl Phthalate (DBP) can be absorbed by dermal exposure or inhalation [4]. Once absorbed, phthalates usually undergo a phase I hydrolysis to form the primary metabolites such as Mono-2-ethylhexyl phthalate (MEHP) or Mono-n-butyl phthalate (MnBP), and may proceed to further hydroxylation and oxidation or phase II conjugation before they are excreted in urine and feces [5]. Since most metabolites are excreted through urine, the urinary metabolites of phthalates are useful indices for the evaluation of phthalate exposure. MnBP, the primary metabolite of DBP, could be an appropriate biomarker for DBP exposure, since 84 % of absorbed DBP is excreted as MnBP in urine within 24 h of intake [6]. As to DEHP, secondary metabolites such as Mono (2-ethyl-5-oxohexyl) phthalate (MEOHP) and Mono (2-ethyl-5-hydroxylhexyl) phthalate (MEHHP) have been used to predict DEHP exposure [7, 8]. Many investigations have been performed regarding in vivo effects of phthalate exposure since 1970s. An animal study reported testicular atrophy and decrease of reproductive ability in mice exposed to phthalates [9]. An epidemiologic study of human indicated that exposure to phthalates in male during gestation and infancy is related to the decrease of anogenital index and testosterone levels suggesting a possible anti-androgenic effect [10]. Thus, the exposure in pregnant or lactating women and boys has been considered relatively important. However, endocrine disrupting effects of phthalates in adults also have been reported in recent studies. One study showed that phthalate exposure and testosterone levels are negatively correlated in male and female adults aged over 40 years [11]. Other study has suggested that it not only affected reproductive function, but also influenced on insulin-resistance and obesity [12]. Moreover, several studies showed that the prevalence of diseases such as asthma or ADHD has a positive correlation with phthalate exposure and relevant research is still ongoing [13–15]. The effect of phthalates on the human body is not fully investigated yet and the mechanisms involved also remain unclear. There are various products containing phthalates and most people are exposed to these products in daily living. Especially, the inside structures of a building such as flooring materials, wall paper, or window frames are thought to be important sources of phthalate exposure. Larsson et al. reported higher urinary concentrations of * Correspondence: kimdh@paik.ac.kr Department of Occupational and Environmental Medicine, Inje University Haeundae Paik Hospital, 875 Heaundae-ro, Haeundae-Gu, Busan 612-862, South Korea Full list of author information is available at the end of the article